CHRISTINE BITETTI: Open Payments
NPI 1497008155 · WEYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 28 payments from 12 companies in 2025. Trend: 2023 $178 · 2024 $1,288 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $286 |
| Galderma Laboratories, L.P. | 4 | $164 |
| ABBVIE INC. | 8 | $158 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| Janssen Biotech, Inc. | 1 | $39 |
| Organon LLC | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
| LEO Pharma Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: DUPIXENT, NEMLUVIO, RINVOQ, SKYRIZI, COSENTYX, TREMFYA, VTAMA, Sotyktu.
Industry payments across MA — which companies pay providers there.
